Palli Valapila Abdulrouf
Overview
Explore the profile of Palli Valapila Abdulrouf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Razzaq A, Elkahlout R, Nasrallah G, Ibrahim F, Samara M, Zayed H, et al.
Lifestyle Genom
. 2025 Jan;
:1-23.
PMID: 39746347
Introduction: Preterm birth (PTB) is associated with newborn morbidity and mortality. DNA methylation plays an important role in the development of fetus, thus can also serve as an epigenetic biomarker....
2.
Al-Dewik N, Abuarja T, Younes S, Nasrallah G, Alsharshani M, Ibrahim F, et al.
Per Med
. 2024 Sep;
21(5):313-333.
PMID: 39347749
Precision Medicine (PM) is a transformative clinical medicine strategy that aims to revolutionize healthcare by leveraging biological information and biomarkers. In the context of maternal and neonatal health, PM enables...
3.
Al-Hersh E, Abushanab D, AbouNahia F, Rainkie D, Al Hail M, Abdulrouf P, et al.
J Pharm Policy Pract
. 2024 May;
17(1):2345218.
PMID: 38798766
Objective: Preterm babies are prone to experiencing apnea of prematurity (AOP), mostly characterised by a pause in breathing lasting a minimum of 20 seconds. Recent literature supported higher maintenance doses...
4.
Yakti O, Al-Badriyeh D, Rijims M, Abdelaal M, Alsoukhni O, Al Hail M, et al.
J Pharm Policy Pract
. 2024 Jan;
17(1):170-190.
PMID: 38236554
Objective: This study aimed to assess the overall economic impact of clinical pharmacist interventions in the neonatal ICU (NICU) in Qatar. Methods: A retrospective review of neonates' records was performed...
5.
Abushanab D, Atchan M, Elajez R, Elshafei M, Abdelbari A, Al Hail M, et al.
PLoS One
. 2023 Jun;
18(6):e0286419.
PMID: 37262042
Background: With an increasingly strained health system budgets, healthcare services need to continually demonstrate evidence of economic benefits. This study sought to evaluate the economic impact of interventions initiated by...
6.
Al-Sharshani D, Velayutham D, Samara M, Gazal R, Al Haj Zen A, Ismail M, et al.
Mol Genet Genomic Med
. 2023 May;
11(8):e2178.
PMID: 37147786
Background: Dyslipidemia is recognized as one of the risk factors of cardiovascular diseases (CVDs), type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD). Objective: The study aimed to...
7.
Younes S, Ismail M, Al-Jurf R, Ziyada A, Nasrallah G, Abdulrouf P, et al.
Hematology
. 2023 Apr;
28(1):2196866.
PMID: 37078896
Small molecule therapy is a critical component of targeted anticancer treatment, with tyrosine kinase inhibitors (TKIs) being the first compounds to treat the clonal Chronic Myelogenous Leukaemia (CML) translocation t...
8.
Al-Dewik N, Samara M, Younes S, Al-Jurf R, Nasrallah G, Al-Obaidly S, et al.
Sci Rep
. 2023 Feb;
13(1):2198.
PMID: 36750603
Congenital anomalies (CAs) are a leading cause of morbidity and mortality in early life. We aimed to assess the incidence, risk factors, and outcomes of major CAs in the State...
9.
Younes S, Samara M, Salama N, Al-Jurf R, Nasrallah G, Al-Obaidly S, et al.
PLoS One
. 2021 Oct;
16(10):e0258967.
PMID: 34710154
Background: Abnormal fetal growth can be associated with factors during pregnancy and at postpartum. Objective: In this study, we aimed to assess the incidence, risk factors, and feto-maternal outcomes associated...
10.
Younes S, Samara M, Al-Jurf R, Nasrallah G, Al-Obaidly S, Salama H, et al.
Int J Environ Res Public Health
. 2021 Jun;
18(11).
PMID: 34072575
Preterm birth (PTB) and early term birth (ETB) are associated with high risks of perinatal mortality and morbidity. While extreme to very PTBs have been extensively studied, studies on infants...